TrialVascular medicine (London, England)2019
A randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease.
Kerry S Russell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled itcites it